This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Biotechnology: The underutilised tool in the fight for global health and security
ABSTRACT: Biotechnology companies can contribute to developing new treatments for diseases of thedeveloping world without losing money or converting to charity.
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
- Management
- Policy
- Finance
- Law
- Regulation
- Bioethics
For more information, see the Journal of Commercial Biotechnology website